Marilyn K Glassberg MD

PubMed

• Revisiting the INSPIRE trial: antibody profiling reveals high prevalence of occult autoimmunity.
  Marilyn K Glassberg, Cindy Burg, Simone Pereira-Simon, Benjamin Trzaskoma, Lisa Harlow
  Respiratory Research. 2026-01-20
• Managing Acute Exacerbations in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in the Intensive Care Unit Setting.
  Alissa Ali, Marilyn K Glassberg
  Critical Care Nursing Clinics of North America. 2025-09-01
• 5 citations
  Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease.
  Kerri A Johannson, Ayodeji Adegunsoye, Jürgen Behr, Vincent Cottin, Allan R Glanville
  American Journal of Respiratory and Critical Care Medicine. 2025-04-01

Journal Articles

• Sensitivity Analyses of the Change in Forced Vital Capacity in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis  
  Lederer DJ, Bradford WZ, Fagan EA, Glaspole I, Glassberg MK, Glasscock KF, Kardatzke D, King TE Jr, Lancaster LH, Nathan SD, Pereira CA, Sahn SA, Swigris JJ, Noble PW, Chest, 1/9/2015
• Pulmonary Complications of Inflammatory Myopathy  
  Miller SA, Glassberg MK, Ascherman DP, Rheum Dis Clin North Am, 1/1/2015
• A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis  
  King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sa..., N Engl J Med, 1/29/2014

Books/Book Chapters

• Principles of Gender-Specific Medicine 
  Chapter: Rare disease in women; BML and LAM. 
  Glassberg MK, Aliniazee MEditors: Marianne Legato.Edition 2nd,2009
• Principles of Gender-Specific Medicine 
  Glassberg MKEditors: Marianne Legato (Glassberg MK, Pulmonary Section Editor).Edition 2nd,2009
• Principles of Gender-Specific Medicine 
  Chapter: The spectrum of interstitial lung disease in patients with collagen vascular disease 
  Glassberg MK, Aliniazee MEditors: Marianne Legato.Edition 2nd,2009

Abstracts/Posters

• Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.
  Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G., Glassberg MK, et al, N Engl J Med, Idiopathic Pulmonary Fibrosis Clinical Research Network, 1/29/2014
• Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical tr...
  Saketoo LA, Mittoo S, Huscher D, Khanna D, Deallaripa PF, Distler O, Flasherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Boelecka OM, Glassberg MK, et al, Thorax, 1/28/2014
• Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
  Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Glassberg MK, et al, Ann Intern Med, 1/7/2013

Lectures

• "Idiopathic Pulmonary Fibrosis: Raising the Index of Suspicion in Primary Care" 
  Princeton , NJ - 1/30/2015
• "Stem Cell Therapy in Interstitial Lung Disease" 
  Miami Beach, FL - 1/23/2015
• "Pulmonary Fibrosis Management Strategies" 
  Washington, DC - 1/13/2015

Other

• Proactive and comprehensive management of patients with IPF. 
  Glassberg MK, Rosen G, Staton G
  https://www.ipfrally.com/managing-the-ipf-patient
  1/1/2014
• Targeting the Pathophysiology of Idiopathic Pulmonary Fibrosis: Inhibiting Fibrogenetic Processes. 
  Glassberg MK
  http://www.quintilesmeded.com/inhibitingIPF
  1/1/2013
• Current and Investigational Treatment Options for IPF. 
  Glassberg MK, Point of Care360: Idiopathic Pulmonary Fibrosis Edition
  http://www.Projectknowledge.com
  1/1/2013